The National Heart Lung and Blood Institute awarded a purchase order to Bruker Biospin Corp on September 9, 2013, with a ceiling value of $28,681.11 for maintenance and support services on Bruker-manufactured nuclear magnetic resonance spectrometer equipment. Work is performed at Bethesda, Maryland. The order, firm fixed price, supports a closely associated critical function protecting highly specialized proprietary NMR equipment from failure that would interrupt and damage critical research...
The National Heart Lung and Blood Institute awarded a purchase order to Bruker Biospin Corp for $21,183.00 on April 4, 2019, for cryoplatform maintenance of a single-bay two-channel 800 MHz system. Performance is in Bethesda, Maryland. The order covers four quarterly maintenance payments of $5,295.75 each, with a period of performance from May 1, 2019, through April 30, 2020. The procurement was a firm fixed price, full and open competition with no set-aside designation, based on quotation...
<p>The National Heart Lung and Blood Institute issued a purchase order to Bruker Biospin Corp for $22,707.64 on March 31, 2020, for renewed maintenance service on a 600 MHz NMR cryoplatform at the NMR Laboratory in Bethesda, Maryland. The order carries firm fixed-price pricing with an ultimate completion date of March 31, 2021. No set-aside was used. The maintenance service contract ensures continued operation of the equipment without disruption to laboratory research.</p>
The National Heart Lung and Blood Institute awarded a purchase order to Bruker Biospin Corp for cryoplatform maintenance on February 27, 2019, with a ceiling value of $21,183.00 and a firm fixed price of $5,295.75 quarterly. Work is performed at Bethesda, Maryland. The order covers preventive maintenance for a single-bay, two-channel 600 MHz system (System ID BH046804) under four quarterly payments. The period of performance runs April 1, 2019 through March 31, 2020. The purchase order was based...
<p>The National Heart Lung and Blood Institute awarded a purchase order to Bruker Biospin Corp for service agreement support of a NEO 600 MHz NMR cryogenic probe platform, valued at $19,164.86, with an award date of June 30, 2026 and ultimate completion date of June 29, 2027. Work is performed at Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>
<p>The National Heart Lung and Blood Institute issued a purchase order to Bruker Biospin Corp on August 27, 2019, for a Biospec Console 9.4 T with a ceiling value of $955,000.00. Performance occurs in Billerica, Massachusetts. The order is firm fixed price with an ultimate completion date of April 30, 2020. The solicitation was posted August 7, 2019, with a due date of August 12, 2019.</p>
<p>The National Heart Lung and Blood Institute issued a purchase order to Boston Scientific Corp valued at $9,000 on March 1, 2012, for maintenance, repair, and rebuild of laboratory instruments and equipment. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of March 25, 2013. No set-aside was used.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Boston Scientific Corp for maintenance and repair of instruments and laboratory equipment valued at $10,000 on March 25, 2011, with an ultimate completion date of March 24, 2012. Work is performed at Bethesda, Maryland. The order carries firm fixed-price pricing and uses no set-aside designation.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Bio-Rad Laboratories, Inc. for $9,240.00 on October 4, 2012, with ultimate completion on October 4, 2013. The order covers maintenance, repair, and rebuild of laboratory instruments and equipment on a firm fixed-price basis. Work is performed at Bethesda, Maryland.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Jeol USA, Inc. for $10,450.12 on March 2, 2011, for maintenance and repair of instruments and laboratory equipment. Place of performance is Bethesda, Maryland. The order carries a firm fixed price, with ultimate completion scheduled for October 8, 2011. No set-aside was applied.</p>